What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Medications for Weight Loss: The New Satiety Hormones

Scripps Health

K. Fujioka

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Weightloss in Menopause

Susan Brian

Tirzepatide Updates

Diana Isaacs

Mounjaro Update 2024

Susan Brian

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Tirzepatide for Type 2 Diabetes

Diana Isaacs

Obesity: New Understanding and Treatments

Norman Lepor

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

Patricia Kao

Type 2 Diabetes - Medical Management

Michigan Medicine

A. Rothberg

Wegovy 2024 Updates

Susan Brian

Switch, Change, Rearrange: Diabetes Medication Transitions, De-presc…

Jennifer Rosselli

S. Twillmann